Net gamma exposure for Abbott Laboratories (ABT) options was positive at the Nov 4, 2026 close, about $32.27M per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for ABT, 2026-11-06(w), calls & puts
Gamma Exposure Stats
Showing results for ABT, 2026-11-06(w), calls & puts
Net Gamma Exposure by Expiration
Showing results for ABT, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
ABT Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is ABT gamma exposure positive or negative?
Abbott Laboratories net gamma exposure was positive on Nov 4, 2026, at $32.27M. It has been positive on 20 of the last 20 trading days.
How has ABT gamma exposure changed recently?
Abbott Laboratories net gamma exposure went from $6.07M on Oct 7, 2026 to $32.27M on Nov 4, 2026. See the ABT gamma exposure history for a longer view.
What is Abbott Laboratories?
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs.